Charlie Javice’s fraud trial is revealing embarrassing details about the banking giant’s failed deal process.

The most recent trading session ended with JPMorgan Chase & Co. (JPM) standing at $251.13, reflecting a +1.24% shift from the previouse trading day's closing. This move outpaced the S&P 500's daily ...

JPMorgan Chase is altering the name of what was formerly its DEI program. As AFROTECH™ previously told you, JPMorgan Chase ...

Trillium Asset Management LLC reduced its holdings in JPMorgan Chase & Co. (NYSE:JPM – Free Report) by 2.9% in the 4th ...

Enhancing Capital LLC bought a new position in shares of JPMorgan Chase & Co. (NYSE:JPM) in the 4th quarter, Holdings Channel ...

JPMorgan Chase mismanaged employee health benefits, resulting in past and present employees paying inflated prices for ...

At her $175M fraud trial this week, Charlie Javice's defense lawyers will tell a jury JPMorgan misunderstood two things: her ...

The bank said it will swap in “opportunity” for “equity” in its DEI policy and that it left Net-Zero Asset Managers over the ...

Employees filing pioneering suits against companies like JPMorgan Chase & Co. and Johnson & Johnson over prescription drug ...

Employees at banking giant JPMorgan Chase claimed in a new class action suit that the company mismanaged their benefits, ...

BASF SE hired Bank of America Corp. and JPMorgan Chase & Co. to advise it on the potential sale of its coating business, ...

JPMorgan Chase is dropping "equity" from its diversity program as more companies scale back initiatives that are aimed at ...